Popular Articles
Stretch Mark

Industry Lobby Wars Heighten As Reform Efforts Progress
"Healthcare companies are spending millions of dollars and marshaling armies of lobbyists to influence a landmark debate in the U.S. Congress that could dramatically change the way they do business," Reuters reports. "Drugmakers, doctors, insurers and hospitals have opened their wallets, spending more than $1 million a day to buy a voice in the escalating political battle over what could be the broadest revamp of healthcare laws in decades." And "as the debate has unfolded, key lawmakers have seen a surge in campaign donations, and hundreds of lobbyists have jammed Capitol hallways and lined the reception room outside the Senate chamber to talk to lawmakers." Sheila Krumholz, executive director of the Center for Responsive Politics, says "there is a frenzy going on to get in your two cents worth before the legislation reaches the next stage."
generic viagra online
Additional Phase II Data Demonstrate Improvement In Reported Symptoms In Patients Who Still Experience GERD Symptoms Despite PPI Therapy
Adding AZD3355, a novel GABAB receptor agonist, to a proton pump inhibitor (PPI) in patients with Gastroesophageal Reflux Disease (GERD), resulted in a 35% reduction in the mean total number of reflux episodes 0-24 hours after dose, compared with placebo.[i] These data were presented at the Digestive Diseases Week annual meeting (DDW®, 30 May - 4 June, Chicago).
News of the day
World Bank Report Predicts Contracting Global Economy Will Hurt Poorest Countries
The World Bank released a report Monday, projecting "a 2.9 percent contraction in global GDP this year, as rich countries contract by 4.5 percent," the Wall Street Journal reports. "The crisis of the past two years is having dramatic effects on capital flows to developing countries, and the world appears to be entering an era of lower growth," World Bank Chief Economist Justin Lin said (Burns, Wall Street Journal, 6/22).
Cardiovascular

Royal Pharmaceutical Society Calls For Older People To Review Their Medicine With A Pharmacist

New research released by the Royal Pharmaceutical Society of Great Britain (RPSGB) reveals how older people are taking a cocktail of medicine without fully understanding what they are or the side effects they are causing. The RPSGB survey shows that nearly half (43%) of over 65"s are currently taking over five medicines at any one time. However, one in five admits to not always taking the medicine as prescribed. Sixty per cent also believe that they either definitely or possibly have had a side effect from medicine - yet one if five said they did not get it checked out. In response to these findings, the RPSGB is launching a campaign to urge older people to review the medicine they are taking by visiting their local pharmacist for a Medicine Use Review (MUR). MURs are undertaken by local pharmacies to help patients manage their medicine more effectively and can be done on an annual basis. It involves a consultation with a pharmacist and can be offered to anyone on one or more medicines and/ or long term conditions. Royal Pharmaceutical Society spokesman and pharmacist, Paul Johnson says; "It"s not unusual for older people to get confused with the medicine they are taking, particularly when they are on numerous types of medication. As a result, they may also not realise the reactions they may be causing when they are not used properly. "Pharmacists are easily accessible and are ideally placed to provide advice to a patient on their medicine which can really improve someone"s health or even their quality of life. " Other findings of the research revealed that almost one in 10 (9%) admit to not fully understanding what their medications do or how they treat their condition, and one in seven (14%) say they sometimes forget to take a pill at the recommended time. Royal Pharmaceutical Society of Great Britain


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):